Filter
924
Filtered Results: 924
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
77
New Publications
285
Language
Document type
No document type
478
Studies & Reports
167
Guidelines
137
Manuals
56
Strategic & Response Plan
51
Fact sheets
14
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
39
India
32
Uganda
27
South Africa
23
Global
22
Liberia
21
Nigeria
19
Ghana
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Bangladesh
15
Malawi
15
Nepal
14
Namibia
13
Western and Central Europe
13
Zimbabwe
10
Ukraine
10
Syria
9
Cambodia
9
Myanmar / Burma
9
Philippines
8
Lesotho
8
Botswana
7
Africa
7
Eastern Europe
7
South–East Asia Region
6
Indonesia
5
Eswatini/ Swaziland
5
West and Central Africa
5
Congo, Democratic Republic of
4
East and Southern Africa
4
Western Pacific Region
4
Latin America and the Carribbean
4
Guinea
3
Burkina Faso
3
Pakistan
3
Jordan
3
Thailand
3
Benin
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Albania
3
Senegal
2
USA
2
Cameroon
2
Haiti
2
Mozambique
2
Asia
2
Laos
2
Mali
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
North Macedonia
1
Madagascar
1
Fiji
1
Timor Leste/ East Timor
1
Russia
1
Moldova
1
Iran
1
Australia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
413
Clinical Guidelines
57
Public Health
36
Key Resources
29
Pharmacy & Technologies
27
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
120
Pharmacy
117
COVID-19
53
HIV
38
TB
38
Rapid Response
34
Mental Health
32
Global Health Education
20
Planetary Health
19
Conflict
14
Caregiver
14
Ebola
13
Specific Hazards
10
NCDs
10
NTDs
9
Health Financing Toolbox
9
Polio
5
Disability
2
Natural Hazards
2
Refugee
2
Zika
2
Social Ethics
1
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
The Ebola outbreak that started in December 2013 became a public
health, humanitarian and socioeconomic crisis with a devastating
impact on families, communities and affected countries. It also served
as a reminder that the world, including WHO, is ill-prepared for a large
and sustained disease ...
Zambia National Health Strategic Plan 2017-2021
recommended
Project Paper to provide an additional grant for: Human Development Systems Strengthening Project (HDSSP)(P145965, H9360)
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
The Third Rwandan Health Sector Strategic Plan (HSSP III) provides strategic guidance to the health sector for six years, between July 2012 and June 2018. HSSP III has been inspired and guided by the VISION 2020, which will make Rwanda a lower-middle-income country by 2020; the Rwandan Health Policy...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Accessed November, 2017
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
